Related references
Note: Only part of the references are listed.Phosphoproteomic evaluation of pharmacological inhibition of leucine-rich repeat kinase 2 reveals significant off-target effects of LRRK-2-IN-1
Gregory C. Luerman et al.
JOURNAL OF NEUROCHEMISTRY (2014)
RAB7L1 Interacts with LRRK2 to Modify Intraneuronal Protein Sorting and Parkinson's Disease Risk
David A. MacLeod et al.
NEURON (2013)
Short- and Long-Term Effects of LRRK2 on Axon and Dendrite Growth
Bryan Sepulveda et al.
PLOS ONE (2013)
Mechanisms of LRRK2-Mediated Neurodegeneration
Elpida Tsika et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2012)
Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease
Adriana Sanchez-Danes et al.
EMBO MOLECULAR MEDICINE (2012)
Primary Skin Fibroblasts as a Model of Parkinson's Disease
Georg Auburger et al.
MOLECULAR NEUROBIOLOGY (2012)
Chemotaxis: Movement, direction, control
A. V. Vorotnikov
BIOCHEMISTRY-MOSCOW (2011)
Role of LRRK2 kinase dysfunction in Parkinson disease
Azad Kumar et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2011)
Rac1 Protein Rescues Neurite Retraction Caused by G2019S Leucine-rich Repeat Kinase 2 (LRRK2)
Diane Chan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
A QUICK Screen for Lrrk2 Interaction Partners - Leucine-rich Repeat Kinase 2 is Involved in Actin Cytoskeleton Dynamics
Andrea Meixner et al.
MOLECULAR & CELLULAR PROTEOMICS (2011)
Association of LRRK2 exonic variants and susceptibility to Parkinson's disease: a case-control study (vol 10, pg 898, 2011)
O. A. Ross et al.
LANCET NEUROLOGY (2011)
Genetic LRRK2 Models of Parkinson's Disease: Dissecting the Pathogenic Pathway and Exploring Clinical Applications
Zhenyu Yue et al.
MOVEMENT DISORDERS (2011)
Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2
Xianming Deng et al.
NATURE CHEMICAL BIOLOGY (2011)
Adult neurogenesis and neurite outgrowth are impaired in LRRK2 G2019S mice
B. Winner et al.
NEUROBIOLOGY OF DISEASE (2011)
Mouse models for LRRK2 Parkinson's disease
Qing Xu et al.
PARKINSONISM & RELATED DISORDERS (2011)
Dopaminergic Neuronal Loss, Reduced Neurite Complexity and Autophagic Abnormalities in Transgenic Mice Expressing G2019S Mutant LRRK2
David Ramonet et al.
PLOS ONE (2011)
Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study
Owen A. Ross et al.
LANCET NEUROLOGY (2011)
Changes in adhesion efficiency and vimentin distribution of fibroblasts from familial Alzheimer's disease patients
M. Takeda et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
The Genetics of Parkinson Disease
Lynn M. Bekris et al.
JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY (2010)
The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease
Mark R. Cookson
NATURE REVIEWS NEUROSCIENCE (2010)
Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice
H. L. Melrose et al.
NEUROBIOLOGY OF DISEASE (2010)
A comparative study of Lrrk2 function in primary neuronal cultures
Justus C. Daechsel et al.
PARKINSONISM & RELATED DISORDERS (2010)
ARHGEF7 (BETA-PIX) Acts as Guanine Nucleotide Exchange Factor for Leucine-Rich Repeat Kinase 2
Karina Haebig et al.
PLOS ONE (2010)
LRRK2 Gene Variation and Its Contribution to Parkinson Disease
Coro Paisan-Ruiz
HUMAN MUTATION (2009)
Homo- and heterodimerization of ROCO kinases: LRRK2 kinase inhibition by the LRRK2 ROCO fragment
Christian L. Klein et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Phosphorylation of Ezrin/Radixin/Moesin Proteins by LRRK2 Promotes the Rearrangement of Actin Cytoskeleton in Neuronal Morphogenesis
Loukia Parisiadou et al.
JOURNAL OF NEUROSCIENCE (2009)
Leucine-Rich Repeat Kinase 2 Regulates the Progression of Neuropathology Induced by Parkinson's-Disease-Related Mutant α-synuclein
Xian Lin et al.
NEURON (2009)
The Roco protein family:: a functional perspective
Ignacio Marin et al.
FASEB JOURNAL (2008)
Parkinson's disease: A genetic perspective
Andrea C. Belin et al.
FEBS JOURNAL (2008)
Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells
Edward D. Plowey et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Developmental regulation of leucine-rich repeat kinase 1 and 2 expression in the brain and other rodent and human organs: Implications for Parkinson's disease
M. Westerlund et al.
NEUROSCIENCE (2008)
Dynamic and redundant regulation of LRRK2 and LRRK1 expression
Saskia Biskup et al.
BMC NEUROSCIENCE (2007)
The familial parkinsonism gene LRRK2 regulates neurite process morphology
David MacLeod et al.
NEURON (2006)
Localization of LRRK2 to membranous and vesicular structures in mammalian brain
Saskia Biskup et al.
ANNALS OF NEUROLOGY (2006)
LRRK2 in Parkinson's disease: protein domains and functional insights
Ignacio F. Mata et al.
TRENDS IN NEUROSCIENCES (2006)
LRRK2 expression linked to dopamine-innervated areas
D Galter et al.
ANNALS OF NEUROLOGY (2006)
Abnormalities in cellular adhesion of neuroblastoma and fibroblast models of Lesch Nyhan syndrome
NC Stacey et al.
NEUROSCIENCE (2000)
Share Paper
